课题基金 / 基金详情

Real-world effectiveness of direct-acting antiviral therapy for chronic hepatitis C among HIV co-infected Canadians receiving clinical care

Real-world effectiveness of direct-acting antiviral therapy for chronic hepatitis C among HIV co-infected Canadians receiving clinical care
直接作用抗病毒治疗对接受临床护理的艾滋病毒合并感染加拿大人慢性丙型肝炎的真实效果
批准号：
368162
负责人：
Rossi Carmine
金额：
$0.06万
依托单位：
Research Institute of the McGill University Health Centre
依托单位国家：
加拿大
项目类别：
财政年份：
2017
资助国家：
加拿大
项目状态：
已结题
起止时间：
2017-07-01 至 2018-07-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=368162&lang=en
关键词：
Ics Travel Awards

项目摘要

项目成果

Rossi Carmine的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Chronic hepatitis C virus (HCV) infection is an important comorbid condition that affects as many as 1 in 3 people living with HIV. If left untreated, chronic HCV can increase the risk of serious liver diseases, including cirrhosis and liver cancer. Among
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Impact of chronic hepatitis C virus (HCV) direct-acting antiviral therapy on extrahepatic manifestations among HIV co-infected British Columbians engaged in clinical care
Population-level impact of direct-acting antiviral (DAA) therapies for chronic hepatitis C on extrahepatic manifestations
Rates and Risk Factors for Hepatitis C Re-Infection or Late Relapse after Sustained Virologic Response to Treatment among HIV Co-Infected Canadians
Injection Cocaine Use and Renal Function Decline among Hepatitis C-HIV Co-Infected Canadians Receiving Clinical Care